A Janus kinase (JAK) inhibitor outperformed tumor necrosis factor (TNF) blockers for substantially reducing rheumatoid arthritis (RA) symptoms in patients for whom conventional anti-rheumatic drugs ...
LONDON (Reuters) - In a change of tack, Britain's healthcare cost watchdog NICE has recommended the use of Bristol-Myers Squibb's rheumatoid arthritis drug Orencia by the state health service ...
(Reuters) - Cigna said on Monday it will remove AbbVie’s blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimbursement in 2025, and recommend less pricey ...
New Test May Help Patients With RA Avoid Useless Treatment BATTER-UP Consortium will test 8-gene biomarker set for identifying patients with RA who are unlikely to respond to TNF inhibitors. Medscape ...
UnitedHealth to Remove AbbVie's Humira From Some US Drug Reimbursement Lists Next Year UnitedHealth Group said on Tuesday it will remove AbbVie’s blockbuster rheumatoid arthritis drug Humira from some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback